These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16621242)

  • 1. Is the increase in osteoporosis prevention a result of the audit?
    Naunton M
    Clin Neurol Neurosurg; 2006 Oct; 108(7):718-9. PubMed ID: 16621242
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoporosis treatment: choices and options].
    Reginster JY
    Pol Arch Med Wewn; 2007 Jul; 117(7):283-4. PubMed ID: 17966592
    [No Abstract]   [Full Text] [Related]  

  • 4. [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2006 Nov; 16(11):1834-42. PubMed ID: 17079850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
    Sato S
    Clin Calcium; 2007 Apr; 17(4):600-5. PubMed ID: 17404491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture prevention in postmenopausal women.
    Mosekilde L; Vestergaard P; Langdahl B
    Clin Evid; 2006 Jun; (15):1543-60. PubMed ID: 16973058
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of Corticosteroid-Induced Osteoporosis: A Practical Approach for the Dermatologist.
    Vico-Alonso C; Maroñas-Jiménez L; Lozano-Morillo F
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):357-358. PubMed ID: 29162226
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonates. A cornerstone of osteoporosis treatment.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
    [No Abstract]   [Full Text] [Related]  

  • 9. Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis.
    Dougherty JA
    Ann Pharmacother; 2002 Mar; 36(3):512-6. PubMed ID: 11895066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New guideline for the treatment of osteoporosis].
    Matsumoto T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():387-91. PubMed ID: 15035157
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium and vitamin D therapy in corticosteroid bone loss: what is the evidence.
    Sambrook PN
    J Rheumatol; 1996 Jun; 23(6):963-4. PubMed ID: 8782123
    [No Abstract]   [Full Text] [Related]  

  • 12. [Osteoporosis in the elderly--diagnosis and treatment].
    Gärtner R
    MMW Fortschr Med; 2005 Feb; 147(7):33, 35-6. PubMed ID: 18441582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis in older people: a tale of two studies (and three treatments).
    Troen BR
    J Am Geriatr Soc; 2006 May; 54(5):853-5. PubMed ID: 16696755
    [No Abstract]   [Full Text] [Related]  

  • 14. [Corticosteroid-induced osteoporosis-- prevention and treatment].
    Elkayam O; Paran D; Yaron M; Caspi D
    Harefuah; 1999 Mar; 136(6):489-92. PubMed ID: 10914270
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis: hope on the HORIZON.
    Gennari L; Bilezikian JP
    Lancet; 2009 Apr; 373(9671):1225-6. PubMed ID: 19362657
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteoporosis drugs in real-world clinical practice: an analysis of persistence.
    Iolascon G; Gimigliano F; Orlando V; Capaldo A; Di Somma C; Menditto E
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S137-41. PubMed ID: 24046038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiresorptive treatment after proximal femur fracture].
    Muñoz VL; Roger DR; Valle MB; García LL
    Aten Primaria; 2005 Nov; 36(8):467. PubMed ID: 16287563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role for bisphosphonates in IBD?
    Bernstein CN; Targownik LE; Leslie WD
    Gut; 2014 Sep; 63(9):1369-70. PubMed ID: 24221457
    [No Abstract]   [Full Text] [Related]  

  • 19. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.
    Curtis JR; Westfall AO; Cheng H; Saag KG; Delzell E
    Osteoporos Int; 2009 Jun; 20(6):973-8. PubMed ID: 18946630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of treatment modalities for postmenopausal osteoporosis.
    Hamdy RC; Chesnut CH; Gass ML; Holick MF; Leib ES; Lewiecki ME; Maricic M; Watts NB
    South Med J; 2005 Oct; 98(10):1000-14; quiz 1015-7, 1048. PubMed ID: 16295815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.